Advancing Cannabinoid Research and Market Expansion| Aras Azadian, CEO, Avicanna Inc. 00:10:00
The interview provides a comprehensive overview of a Canadian biopharmaceutical company specializing in cannabinoid research and development, emphasizing evidence-based products. The CEO discusses the company's inception, research collaborations, market presence, and future plans, highlighting its focus on medical and pharmaceutical applications. Additionally, insights into European operations and investment opportunities are shared, reflecting the company's strategic expansion and commitment to innovation in the cannabinoid space